PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 12140833

Erector set.

A Saphir
View original source ↗Export metadata ↓

Abstract

It was an untold story in Washington this year: while hospital associations were clamoring for Medicare givebacks from Congress, a miniboom in construction was under way, as some profitable hospitals built new facilities or additions to meet growing patient demand in their markets.

Explore related subjects

Capital ExpendituresCatchment Area, HealthData CollectionFinancial Management, HospitalFinancing, ConstructionHospital Design and ConstructionMarketing of Health ServicesPublic RelationsUnited StatesJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

A Saphir. 1999-12-06. Erector set.. https://pubmed.ncbi.nlm.nih.gov/12140833/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2003

The price of innovation: new estimates of drug development costs.

The research and development costs of 68 randomly selected new drugs were obtained from a survey of 10 pharmaceutical firms. These data were used to estimate the average pre-tax cost of new drug development. The costs of compounds abandoned during testing were linked to the costs of compounds that obtained marketing approval. The estimated average out-of-pocket cost per new drug is 403 million US dollars (2000 dollars). Capitalizing out-of-pocket costs to the point of marketing approval at a real discount rate of 11% yields a total pre-approval cost estimate of 802 million US dollars (2000 dollars). When compared to the results of an earlier study with a similar methodology, total capitalized costs were shown to have increased at an annual rate of 7.4% above general price inflation.

Capital Expenditures↗
PubMed2003

Evaluating group purchasing organizations.

A formal evaluation process can help healthcare organizations assess the current and/or potential value of a group purchasing organization (GPO). Healthcare organizations should approach a GPO evaluation as if they were entering into a new relationship. The evaluation should include purchasing and financial services, value-added services, and corporate relations/business practices. Healthcare organizations should consider the potential economies of scale and other services offered by a GPO. Healthcare organizations should consider using acceptable substitutes for products currently used or seeking products through alternative sources if doing so achieves greater value.

Capital Expenditures↗